{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:44:18Z","timestamp":1767339858246},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,5]],"date-time":"2014-01-05T00:00:00Z","timestamp":1388880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11940-013-0271-4","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T05:56:59Z","timestamp":1388815019000},"source":"Crossref","is-referenced-by-count":14,"title":["Treatment of Endocrine Disorders in the Neuroscience Intensive Care Unit"],"prefix":"10.1007","volume":"16","author":[{"given":"Janice J.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Y.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,5]]},"reference":[{"key":"271_CR1","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","volume":"356","author":"DH Ellison","year":"2007","unstructured":"Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064\u201372.","journal-title":"N Engl J Med"},{"key":"271_CR2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12028-012-9805-y","volume":"18","author":"MA Kirkman","year":"2013","unstructured":"Kirkman MA, Albert AF, Ibrahim A, Doberenz D. Hyponatremia and brain injury: historical and contemporary perspectives. Neurocrit Care. 2013;18:406\u201316. This article is a thorough review of hyponatremia as it relates to neurocritical care management.","journal-title":"Neurocrit Care"},{"key":"271_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11910-012-0284-5","volume":"12","author":"WL Wright","year":"2012","unstructured":"Wright WL. Sodium and fluid management in acute brain injury. Curr Neurol Neurosci Rep. 2012;12:466\u201373.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"271_CR4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.STR.31.1.118","volume":"31","author":"GE Sviri","year":"2000","unstructured":"Sviri GE, Feinsod M, Soustiel JF. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage. Clinical and TCD correlations. Stroke. 2000;31:118\u201322.","journal-title":"Stroke"},{"key":"271_CR5","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/01.STR.29.8.1584","volume":"29","author":"M Tomida","year":"1998","unstructured":"Tomida M, Muraki M, Uemura K, Yamasaki K. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke. 1998;29:1584\u20137.","journal-title":"Stroke"},{"key":"271_CR6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00006123-200204000-00012","volume":"50","author":"AI Qureshi","year":"2002","unstructured":"Qureshi AI, Suri MF, Sung GY, et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;50:749\u201355. discussion 755\u201346.","journal-title":"Neurosurgery"},{"key":"271_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.298.6665.2","volume":"298","author":"J Seckl","year":"1989","unstructured":"Seckl J, Dunger D. Postoperative diabetes insipidus. BMJ. 1989;298:2\u20133.","journal-title":"BMJ"},{"key":"271_CR8","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/bmj.303.6815.1465","volume":"303","author":"B McIver","year":"1991","unstructured":"McIver B, Connacher A, Whittle I, et al. Adipsic hypothalamic diabetes insipidus after clipping of anterior communicating artery aneurysm. BMJ. 1991;303:1465\u20137.","journal-title":"BMJ"},{"key":"271_CR9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.298.12.1429","volume":"298","author":"HJ Schneider","year":"2007","unstructured":"Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, et al. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA. 2007;298:1429\u201338.","journal-title":"JAMA"},{"key":"271_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/brain\/86.2.301","volume":"86","author":"MR Crompton","year":"1963","unstructured":"Crompton MR. Hypothalamic lesions following the rupture of cerebral berry aneurysms. Brain. 1963;86:301\u201314.","journal-title":"Brain"},{"key":"271_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.2010.03791.x","volume":"73","author":"M Klose","year":"2010","unstructured":"Klose M, Brennum J, Poulsgaard L, et al. Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage. Clin Endocrinol. 2010;73:95\u2013101. These two papers are amongst the few studies available examining acute pituitary function following subarachnoid hemorrhage.","journal-title":"Clin Endocrinol"},{"key":"271_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF03347460","volume":"34","author":"G Parenti","year":"2011","unstructured":"Parenti G, Cecchi PC, Ragghianti B, et al. Evaluation of the anterior pituitary function in the acute phase after spontaneous subarachnoid hemorrhage. J Endocrinol Invest. 2011;34:361\u20135. These two papers are amongst the few studies available examining acute pituitary function following subarachnoid hemorrhage.","journal-title":"J Endocrinol Invest"},{"key":"271_CR13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa020266","volume":"350","author":"AH Hamrahian","year":"2004","unstructured":"Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350:1629\u201338.","journal-title":"N Engl J Med"},{"key":"271_CR14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3171\/2009.4.JNS081377","volume":"112","author":"P Gomis","year":"2010","unstructured":"Gomis P, Graftieaux JP, Sercombe R, et al. Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2010;112:681\u20138.","journal-title":"J Neurosurg"},{"key":"271_CR15","first-page":"373","volume":"40","author":"K Hashi","year":"1988","unstructured":"Hashi K, Takakura K, Sano K, et al. Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage\u2013results of a multi-center controlled double-blind clinical study. No To Shinkei. 1988;40:373\u201382.","journal-title":"No To Shinkei"},{"key":"271_CR16","first-page":"1","volume":"60","author":"VG Coronado","year":"2011","unstructured":"Coronado VG, Xu L, Basavaraju SV, et al. Surveillance for traumatic brain injury-related deaths\u2014United States, 1997-2007. MMWR Surveill Summ. 2011;60:1\u201332.","journal-title":"MMWR Surveill Summ"},{"key":"271_CR17","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1210\/jc.2004-0511","volume":"89","author":"A Agha","year":"2004","unstructured":"Agha A, Rogers B, Sherlock M, et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab. 2004;89:4929\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"271_CR18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2265.2004.02023.x","volume":"60","author":"A Agha","year":"2004","unstructured":"Agha A, Rogers B, Mylotte D, et al. Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Clin Endocrinol. 2004;60:584\u201391.","journal-title":"Clin Endocrinol"},{"key":"271_CR19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.surneu.2006.11.052","volume":"68","author":"N Moro","year":"2007","unstructured":"Moro N, Katayama Y, Igarashi T, et al. Hyponatremia in patients with traumatic brain injury: incidence, mechanism, and response to sodium supplementation or retention therapy with hydrocortisone. Surg Neurol. 2007;68:387\u201393.","journal-title":"Surg Neurol"},{"key":"271_CR20","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1097\/01.CCM.0000181735.51183.A7","volume":"33","author":"P Cohan","year":"2005","unstructured":"Cohan P, Wang C, McArthur DL, et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med. 2005;33:2358\u201366.","journal-title":"Crit Care Med"},{"key":"271_CR21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.0013-9580.2004.59403.x","volume":"45","author":"NF Watson","year":"2004","unstructured":"Watson NF, Barber JK, Doherty MJ, et al. Does glucocorticoid administration prevent late seizures after head injury? Epilepsia. 2004;45:690\u20134.","journal-title":"Epilepsia"},{"key":"271_CR22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","volume":"364","author":"I Roberts","year":"2004","unstructured":"Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14\u00a0days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo-controlled trial. Lancet. 2004;364:1321\u20138.","journal-title":"Lancet"},{"key":"271_CR23","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","volume":"365","author":"P Edwards","year":"2005","unstructured":"Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6\u00a0months. Lancet. 2005;365:1957\u20139.","journal-title":"Lancet"},{"key":"271_CR24","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1210\/jc.2004-1058","volume":"89","author":"A Agha","year":"2004","unstructured":"Agha A, Thornton E, O'Kelly P, et al. Posterior pituitary dysfunction after traumatic brain injury. J Clin Endocrinol Metab. 2004;89:5987\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"271_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cen.12010","volume":"78","author":"N Glynn","year":"2013","unstructured":"Glynn N, Agha A. Which patient requires neuroendocrine assessment following traumatic brain injury, when and how? Clin Endocrinol. 2013;78:17\u201320. This article contains an in-depth review of the evaluation of acute and chronic pituitary injury following traumatic brain injury.","journal-title":"Clin Endocrinol"},{"key":"271_CR26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2265.1999.00666.x","volume":"50","author":"J Hensen","year":"1999","unstructured":"Hensen J, Henig A, Fahlbusch R, et al. Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol. 1999;50:431\u20139.","journal-title":"Clin Endocrinol"},{"key":"271_CR27","volume-title":"Williams textbook of endocrinology","author":"H Kronenberg","year":"2008","unstructured":"Kronenberg H, Williams RH. Williams textbook of endocrinology. 11th ed. Philadelphia, PA: Saunders\/Elsevier; 2008.","edition":"11"},{"key":"271_CR28","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/j.healun.2004.06.017","volume":"23","author":"M Smith","year":"2004","unstructured":"Smith M. Physiologic changes during brain stem death\u2013lessons for management of the organ donor. J Heart Lung Transplant. 2004;23:S217\u201322.","journal-title":"J Heart Lung Transplant"},{"key":"271_CR29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.beem.2011.03.003","volume":"25","author":"AM Ranasinghe","year":"2011","unstructured":"Ranasinghe AM, Bonser RS. Endocrine changes in brain death and transplantation. Best Pract Res Clin Endocrinol Metab. 2011;25:799\u2013812.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"271_CR30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.athoracsur.2007.07.092","volume":"85","author":"RV Venkateswaran","year":"2008","unstructured":"Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008;85:278\u201386. discussion 286.","journal-title":"Ann Thorac Surg"},{"key":"271_CR31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ALN.0b013e3181d4f34d","volume":"112","author":"A Nicolas-Robin","year":"2010","unstructured":"Nicolas-Robin A, Barouk JD, Amour J, et al. Hydrocortisone supplementation enhances hemodynamic stability in brain-dead patients. Anesthesiology. 2010;112:1204\u201310.","journal-title":"Anesthesiology"},{"key":"271_CR32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/TP.0b013e3181b11e5d","volume":"88","author":"RV Venkateswaran","year":"2009","unstructured":"Venkateswaran RV, Dronavalli V, Lambert PA, et al. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. Transplantation. 2009;88:582\u20138.","journal-title":"Transplantation"},{"key":"271_CR33","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(98)05456-7","volume":"352","author":"R Guesde","year":"1998","unstructured":"Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet. 1998;352:1178\u201381.","journal-title":"Lancet"},{"key":"271_CR34","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00007890-198905000-00016","volume":"47","author":"TA Howlett","year":"1989","unstructured":"Howlett TA, Keogh AM, Perry L, et al. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation. 1989;47:828\u201334.","journal-title":"Transplantation"},{"key":"271_CR35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00007890-199211000-00016","volume":"54","author":"HJ Gramm","year":"1992","unstructured":"Gramm HJ, Meinhold H, Bickel U, et al. Acute endocrine failure after brain death? Transplantation. 1992;54:851\u20137.","journal-title":"Transplantation"},{"key":"271_CR36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00007890-199210000-00034","volume":"54","author":"TT Randell","year":"1992","unstructured":"Randell TT, Hockerstedt KA. Triiodothyronine treatment in brain-dead multiorgan donors\u2014a controlled study. Transplantation. 1992;54:736\u20138.","journal-title":"Transplantation"},{"key":"271_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1213\/00000539-199607000-00008","volume":"83","author":"JP Goarin","year":"1996","unstructured":"Goarin JP, Cohen S, Riou B, et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg. 1996;83:41\u20137.","journal-title":"Anesth Analg"},{"key":"271_CR38","doi-asserted-by":"crossref","first-page":"R203","DOI":"10.1186\/cc11812","volume":"16","author":"AH Kramer","year":"2012","unstructured":"Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16:R203. This review and meta-analysis addresses management of glycemic control specifically with regards to neurocritical care patients.","journal-title":"Crit Care"},{"key":"271_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12028-009-9249-1","volume":"11","author":"DE Griesdale","year":"2009","unstructured":"Griesdale DE, Tremblay MH, McEwen J, Chittock DR. Glucose control and mortality in patients with severe traumatic brain injury. Neurocrit Care. 2009;11:311\u20136.","journal-title":"Neurocrit Care"},{"key":"271_CR40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1212\/01.WNL.0000090466.68866.02","volume":"61","author":"SM Dorhout Mees","year":"2003","unstructured":"Dorhout Mees SM, van Dijk GW, Algra A, et al. Glucose levels and outcome after subarachnoid hemorrhage. Neurology. 2003;61:1132\u20133.","journal-title":"Neurology"},{"key":"271_CR41","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/01.CCM.0000168054.60538.2B","volume":"33","author":"N Badjatia","year":"2005","unstructured":"Badjatia N, Topcuoglu MA, Buonanno FS, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med. 2005;33:1603\u20139.","journal-title":"Crit Care Med"},{"key":"271_CR42","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1212\/01.WNL.0000094326.30791.2D","volume":"61","author":"S Passero","year":"2003","unstructured":"Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology. 2003;61:1351\u20136.","journal-title":"Neurology"},{"key":"271_CR43","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Berghe van den","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359\u201367.","journal-title":"N Engl J Med"},{"key":"271_CR44","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"N-SS Investigators","year":"2009","unstructured":"Investigators N-SS, Finfer S, Chittock DR, et al. Intensive vs. conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283\u201397.","journal-title":"N Engl J Med"},{"key":"271_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125\u201339.","journal-title":"N Engl J Med"},{"key":"271_CR46","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1097\/CCM.0b013e31818f21aa","volume":"36","author":"YM Arabi","year":"2008","unstructured":"Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive vs. conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190\u20137.","journal-title":"Crit Care Med"},{"key":"271_CR47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jama.300.8.933","volume":"300","author":"RS Wiener","year":"2008","unstructured":"Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300:933\u201344.","journal-title":"JAMA"},{"key":"271_CR48","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4158\/EP.13.4.384","volume":"13","author":"F Ajaz","year":"2007","unstructured":"Ajaz F, Kudva YC, Erwin PJ. Residual dysphasia after severe hypoglycemia in a patient with immune-mediated primary adrenal insufficiency and type 1 diabetes mellitus: case report and systematic review of the literature. Endocr Pract. 2007;13:384\u20138.","journal-title":"Endocr Pract"},{"key":"271_CR49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/030006059602400607","volume":"24","author":"H Kurabayashi","year":"1996","unstructured":"Kurabayashi H, Kubota K, Tamura K, et al. Motor aphasia due to prolonged hypoglycaemic coma in a patient with insulin-dependent diabetes mellitus. J Int Med Res. 1996;24:487\u201391.","journal-title":"J Int Med Res"},{"key":"271_CR50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00688108","volume":"64","author":"RN Auer","year":"1984","unstructured":"Auer RN, Wieloch T, Olsson Y, Siesjo BK. The distribution of hypoglycemic brain damage. Acta Neuropathol. 1984;64:177\u201391.","journal-title":"Acta Neuropathol"},{"key":"271_CR51","doi-asserted-by":"crossref","unstructured":"Guettier JM, Gorden P. Hypoglycemia. Endocrinol Metab Clin North Am. 2006;35:753\u201366, viii\u2013ix.","DOI":"10.1016\/j.ecl.2006.09.005"},{"key":"271_CR52","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0889-8529(05)70288-7","volume":"26","author":"FJ Service","year":"1997","unstructured":"Service FJ. Hypoglycemia. Endocrinol Metab Clin North Am. 1997;26:937\u201355.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"271_CR53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/0026-0495(93)90266-Q","volume":"42","author":"R Arem","year":"1993","unstructured":"Arem R, Wiener GJ, Kaplan SG, et al. Reduced tissue thyroid hormone levels in fatal illness. Metabolism. 1993;42:1102\u20138.","journal-title":"Metabolism"},{"key":"271_CR54","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archinte.159.7.658","volume":"159","author":"J Attia","year":"1999","unstructured":"Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalized patients: a systematic review. Arch Intern Med. 1999;159:658\u201365.","journal-title":"Arch Intern Med"},{"key":"271_CR55","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/clinchem\/33.8.1391","volume":"33","author":"C Spencer","year":"1987","unstructured":"Spencer C, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem. 1987;33:1391\u20136.","journal-title":"Clin Chem"},{"key":"271_CR56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/beem.2001.0164","volume":"15","author":"N Stathatos","year":"2001","unstructured":"Stathatos N, Levetan C, Burman KD, Wartofsky L. The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab. 2001;15:465\u201378.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"271_CR57","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1001\/jama.1981.03320230026019","volume":"246","author":"MF Slag","year":"1981","unstructured":"Slag MF, Morley JE, Elson MK, et al. Free thyroxine levels in critically ill patients. A comparison of currently available assays. JAMA. 1981;246:2702\u20136.","journal-title":"JAMA"},{"key":"271_CR58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.1981.03310260021020","volume":"245","author":"MF Slag","year":"1981","unstructured":"Slag MF, Morley JE, Elson MK, et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA. 1981;245:43\u20135.","journal-title":"JAMA"},{"key":"271_CR59","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00134-005-2719-9","volume":"31","author":"E Chinga-Alayo","year":"2005","unstructured":"Chinga-Alayo E, Villena J, Evans AT, Zimic M. Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit. Intensive Care Med. 2005;31:1356\u201361.","journal-title":"Intensive Care Med"},{"key":"271_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-63-1-1","volume":"63","author":"GA Brent","year":"1986","unstructured":"Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab. 1986;63:1\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"271_CR61","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00003246-198212000-00014","volume":"10","author":"RA Becker","year":"1982","unstructured":"Becker RA, Vaughan GM, Ziegler MG, et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med. 1982;10:870\u20135.","journal-title":"Crit Care Med"},{"key":"271_CR62","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJM199512073332302","volume":"333","author":"JD Klemperer","year":"1995","unstructured":"Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med. 1995;333:1522\u20137.","journal-title":"N Engl J Med"},{"key":"271_CR63","doi-asserted-by":"crossref","unstructured":"Wartofsky L. Myxedema coma. Endocrinol Metab Clin North Am. 2006;35:687\u201398, vii\u2013viii.","DOI":"10.1016\/j.ecl.2006.09.003"},{"key":"271_CR64","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(62)92700-9","volume":"2","author":"EH Jellinek","year":"1962","unstructured":"Jellinek EH. Fits, faints, coma, and dementia in myxoedema. Lancet. 1962;2:1010\u20132.","journal-title":"Lancet"},{"key":"271_CR65","first-page":"1125","volume":"96","author":"GA Edwards","year":"1968","unstructured":"Edwards GA. Neurologic manifestations of myxedema. Med Times. 1968;96:1125\u201330.","journal-title":"Med Times."},{"key":"271_CR66","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bmj.1.5131.1204","volume":"1","author":"EA Nieman","year":"1959","unstructured":"Nieman EA. The electroencephalogram in myxoedema coma: clinical and electroencephalographic study of three cases. BMJ. 1959;1:1204\u20138.","journal-title":"BMJ"},{"key":"271_CR67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/155005949302400313","volume":"24","author":"Y River","year":"1993","unstructured":"River Y, Zelig O. Triphasic waves in myxedema coma. Clin Electroencephalogr. 1993;24:146\u201350.","journal-title":"Clin Electroencephalogr"},{"key":"271_CR68","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","volume":"342","author":"HJ Adrogue","year":"2000","unstructured":"Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581\u20139.","journal-title":"N Engl J Med"},{"issue":"745","key":"271_CR69","first-page":"e741","volume":"27","author":"T Human","year":"2012","unstructured":"Human T, Onuoha A, Diringer M, Dhar R. Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury. J Crit Care. 2012;27(745):e741\u20135.","journal-title":"J Crit Care"},{"key":"271_CR70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12028-008-9179-3","volume":"11","author":"T Murphy","year":"2009","unstructured":"Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care. 2009;11:14\u20139.","journal-title":"Neurocrit Care"},{"key":"271_CR71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-008-9152-1","volume":"11","author":"WL Wright","year":"2009","unstructured":"Wright WL, Asbury WH, Gilmore JL, Samuels OB. Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care. 2009;11:6\u201313.","journal-title":"Neurocrit Care"},{"key":"271_CR72","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12028-009-9238-4","volume":"11","author":"CH Woo","year":"2009","unstructured":"Woo CH, Rao VA, Sheridan W, Flint AC. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. Neurocrit Care. 2009;11:228\u201334.","journal-title":"Neurocrit Care"},{"key":"271_CR73","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4158\/EP11260.OR","volume":"18","author":"S Shetty","year":"2012","unstructured":"Shetty S, Inzucchi SE, Goldberg PA, et al. Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol. Endocr Pract. 2012;18:363\u201370.","journal-title":"Endocr Pract"},{"key":"271_CR74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/193229680800200204","volume":"2","author":"K Kunjan","year":"2008","unstructured":"Kunjan K, Lloyd FP. Automated blood sampling and glucose sensing in critical care settings. J Diabetes Sci Technol. 2008;2:194\u2013200.","journal-title":"J Diabetes Sci Technol"},{"key":"271_CR75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/ALN.0b013e3181ff4187","volume":"114","author":"NK Skjaervold","year":"2011","unstructured":"Skjaervold NK, Solligard E, Hjelme DR, Aadahl P. Continuous measurement of blood glucose: validation of a new intravascular sensor. Anesthesiology. 2011;114:120\u20135.","journal-title":"Anesthesiology"},{"key":"271_CR76","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc09-1352","volume":"33","author":"U Holzinger","year":"2010","unstructured":"Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010;33:467\u201372.","journal-title":"Diabetes Care"},{"key":"271_CR77","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/CCM.0b013e318206bf2e","volume":"39","author":"R Brunner","year":"2011","unstructured":"Brunner R, Kitzberger R, Miehsler W, et al. Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011;39:659\u201364.","journal-title":"Crit Care Med"},{"key":"271_CR78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/152091504774198034","volume":"6","author":"PA Goldberg","year":"2004","unstructured":"Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004;6:339\u201347.","journal-title":"Diabetes Technol Ther"},{"key":"271_CR79","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/193229680900300443","volume":"3","author":"A Rabiee","year":"2009","unstructured":"Rabiee A, Andreasik V, Abu-Hamdah R, et al. Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units. J Diabetes Sci Technol. 2009;3:951\u20139.","journal-title":"J Diabetes Sci Technol"},{"key":"271_CR80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-6576.2008.01799.x","volume":"53","author":"K Yamashita","year":"2009","unstructured":"Yamashita K, Okabayashi T, Yokoyama T, et al. Accuracy and reliability of continuous blood glucose monitor in postsurgical patients. Acta Anaesthesiol Scand. 2009;53:66\u201371.","journal-title":"Acta Anaesthesiol Scand"},{"key":"271_CR81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/ALN.0b013e3181ff419e","volume":"114","author":"SE Inzucchi","year":"2011","unstructured":"Inzucchi SE, Kosiborod M. Continuous glucose monitoring during critical care. Anesthesiology. 2011;114:18\u20139.","journal-title":"Anesthesiology"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0271-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-013-0271-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0271-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T14:51:19Z","timestamp":1716389479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-013-0271-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,5]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1007\/s11940-013-0271-4","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,5]]},"article-number":"271"}}